Sun Pharma Q2 profit rises 10.5% to ₹2,262 cr; revenue up 13%
Sun Pharma MD Dilip Shanghvi says in Q2, Sun Pharma recorded double-digit topline growth and strong margins, driven by market share gain in India, and sustained ramp-up of global specialty biz.
